Literature DB >> 1780335

Nicotine yield as determinant of smoke exposure indicators and puffing behavior.

I Höfer1, R Nil, K Bättig.   

Abstract

Relationships between machine smoking nicotine yield and different smoke exposure indicators were investigated in a cross-sectional study. For each of the four yield classes H (1.0-1.2 mg), M (0.7-0.9 mg), L (0.4-0.6 mg) and U (0.1-0.3 mg) 18 male and 18 female subjects were recruited. The experimental design (2 x 2) included smoking with lip contact or with a flowmeter holder, natural smoking of one cigarette or forced smoking (30 puffs). The analysis of presmoking measures revealed for plasma nicotine H greater than L, U; M greater than U, for plasma cotinine H, M greater than U, and no differences for respiratory CO. Pre- to postsmoking boosts of CO and nicotine increased with yield, but the differences were smaller than those in yield. This partial compensation can be attributed to puffing behavior as revealed by the differences between yield classes with respect to flowmeter measures (puff volume, flow parameters, number of puffs). Contact condition hardly influenced the results. Forced puffing revealed down regulation mechanisms in smoke absorption and, less pronounced, in puffing behavior. Cardiovascular and subjective effects were widely independent of yield. Plasma cotinine appeared as the best smoke exposure indicator, due both to its high retest reliability and its relationship to nicotine yield.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1780335     DOI: 10.1016/0091-3057(91)90335-y

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  12 in total

1.  The contributions of cigarette yield, consumption, inhalation and puffing behaviour to the prediction of smoke exposure.

Authors:  I Höfer; R Nil; F Wyss; K Bättig
Journal:  Clin Investig       Date:  1992 Mar-Apr

2.  Comparison of methods for measurement of smoking behavior: mouthpiece-based computerized devices versus direct observation.

Authors:  Melissa D Blank; Steven Disharoon; Thomas Eissenberg
Journal:  Nicotine Tob Res       Date:  2009-06-11       Impact factor: 4.244

3.  Examining the relation between usual-brand nicotine yield, blood cotinine concentration and the nicotine- "compensation" hypothesis.

Authors:  W S Pritchard; J H Robinson
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

4.  A CNN-LSTM neural network for recognition of puffing in smoking episodes using wearable sensors.

Authors:  Volkan Y Senyurek; Masudul H Imtiaz; Prajakta Belsare; Stephen Tiffany; Edward Sazonov
Journal:  Biomed Eng Lett       Date:  2020-01-30

5.  Cigarette smoking related variation of heart rate and physical activity with ad libitum smoking under field conditions.

Authors:  K Bättig; A Jacober; M Hasenfratz
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Sex/Gender Differences in Cotinine Levels Among Daily Smokers in the Pennsylvania Adult Smoking Study.

Authors:  Allshine Chen; Nicolle M Krebs; Junjia Zhu; Dongxiao Sun; Andrea Stennett; Joshua E Muscat
Journal:  J Womens Health (Larchmt)       Date:  2017-09-05       Impact factor: 2.681

7.  Intravenous Nicotine Self-Administration in Smokers: Dose-Response Function and Sex Differences.

Authors:  Kevin P Jensen; Elise E DeVito; Gerald Valentine; Ralitza Gueorguieva; Mehmet Sofuoglu
Journal:  Neuropsychopharmacology       Date:  2015-12-31       Impact factor: 7.853

8.  Nicotine or tar titration in cigarette smoking behavior?

Authors:  M Hasenfratz; B Baldinger; K Bättig
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

Review 9.  Reconciling human smoking behavior and machine smoking patterns: implications for understanding smoking behavior and the impact on laboratory studies.

Authors:  Catalin Marian; Richard J O'Connor; Mirjana V Djordjevic; Vaughan W Rees; Dorothy K Hatsukami; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study.

Authors:  Teresa R Franklin; Derek Harper; Kyle Kampman; Susan Kildea-McCrea; Will Jens; Kevin G Lynch; Charles P O'Brien; Anna Rose Childress
Journal:  Drug Alcohol Depend       Date:  2009-04-23       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.